Neogen (NEOG) Asset Writedowns and Impairment (2023 - 2025)
Neogen's (NEOG) quarterly Asset Writedowns and Impairment came in at -$470.8 million in Q2 2025, down 84776.26% year-on-year from N/an in Q2 2024, and down 23009.98% quarter-over-quarter from $2.1 million in Q1 2025.
Neogen (NEOG) Asset Writedowns and Impairment (2023 - 2025) Analysis & Trends
Neogen's Asset Writedowns and Impairment history runs 3 years deep, the most recent figure standing at -$470.8 million for Q2 2025.
- On a quarterly basis, Asset Writedowns and Impairment fell 84776.26% year-over-year to -$470.8 million in Q2 2025; TTM through Feb 2026 was -$468.2 million, a 115502.22% decrease from a year earlier, with the FY2024 full-year figure at $556000.0, changed N/A from the prior year.
- Asset Writedowns and Impairment fell to -$470.8 million in Q2 2025 per NEOG's latest filing, from $2.1 million in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $2.1 million in Q1 2025 and bottomed at -$470.8 million in Q2 2025.
- The 3-year median for Asset Writedowns and Impairment is -$716000.0 (2024), against an average of -$94.2 million.
- Biggest YoY gain for Asset Writedowns and Impairment was 387.01% in 2025; the steepest drop was 84776.26% in 2025.
- Year by year, Asset Writedowns and Impairment stood at -$2.3 million in 2023, then soared by 124.17% to $556000.0 in 2024, then slumped by 84776.26% to -$470.8 million in 2025.
- Per Business Quant, the three latest NEOG Asset Writedowns and Impairment figures stand at -$470.8 million (Q2 2025), $2.1 million (Q1 2025), and $556000.0 (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.52 Bn | 176.22 Bn | 6.27 Bn |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn |
| 3 | Medtronic | 108.61 Bn | 99.39 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.35 Bn | 66.90 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.53 Bn | 44.86 Bn | 1.29 Bn |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.49 Bn | 22.36 Bn | 2.07 Bn |
| 10 | Neogen | 2.07 Bn | 1.91 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2025 | -470.80 Mn |
| May 31, 2025 | -470.80 Mn |
| Feb 28, 2025 | 2.06 Mn |
| Feb 28, 2025 | 2.06 Mn |
| May 31, 2024 | 556,000.00 |
| May 31, 2024 | 556,000.00 |
| Feb 29, 2024 | -716,000.00 |
| Feb 29, 2024 | -716,000.00 |
| May 31, 2023 | -2.30 Mn |
| May 31, 2023 | -2.30 Mn |